Please assess the completion status of the following clinical trial:

Trial Title: Campylobacter Enteritis and PI-BD: Dietary Reduction in Carbohydrates

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participation in the CERAMIC study (see linked protocol)~* On-going post infective bowel dysfunction (PI-BD) 3 months after confirmation of Campylobacter spp. in stool sample. This is defined as responding 'No' to the question have your bowels returned to normal since your Campylobacter infection?~* Will consent to use of data and samples acquired for CERAMIC in the analysis of CEDRIC~Exclusion Criteria:~As for CERAMIC study (so already confirmed)~* Pregnancy declared by the candidate~* History declared by the candidate of pre-existing gastrointestinal disorder, including but not limited to: Inflammatory Bowel Disease; Coeliac Disease; Pancreatitis; Gallstone disease (biliary colic, cholecystitis); Diverticulitis; Cancer of the gastrointestinal tract; Irritable Bowel Syndrome~* Reported history of previous resection of any part of the gastrointestinal tract other than appendix or gallbladder~* Intestinal stoma~* Habitual use of opiate analgesics likely to alter bowel function e.g. morphine~* Use of antibiotics in the preceding four weeks other than for treatment of index infection. Any condition where the candidate is likely to require a course of antibiotics in the next 3 months e.g. severe chronic respiratory disease, recurrent urinary tract infection, lower limb ulceration~* Inability to complete the symptom questionnaires e.g. cognitive dysfunction, limiting memory and understanding~* Anyone who in the opinion of the investigator is unlikely to be able to comply with the protocol e.g. cognitive dysfunction, chaotic lifestyle related to substance abuse~Addition criteria for CEDRIC study:~* Use of antibiotics or prescribed probiotics during the CERAMIC study~* Failure to provide research stool samples during CERAMIC study~* Dietary practice not compatible with safe implementation of the trial diet e.g.veganism~* Medical reasons for pre-existing controlled diet that cannot be safely randomised e.g. end-stage kidney disease, diabetes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Normal FODMAP arm (Type: SHAM_COMPARATOR): Low FODMAP dietary advice; participants to supplement diet with oligofructose, a poorly digested carbohydrate that will restore FODMAP content to the diet.
- Low FODMAP arm (Type: EXPERIMENTAL): Low FODMAP dietary advice; participants to supplement with maltodextrin (easily digestible carbohydrate)

Based on this trial design, predict the completion outcome and termination type (if applicable).